Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Consideration and ....
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that its Board of Directors will meet on Thursday, November 13, 2025, at 11:30 A.M. at the registered office in Amritsar, Punjab. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025. The company has also reminded that the trading window for designated persons and their relatives remains closed until 48 hours after the results are declared on November 13, 2025. The intimation has been signed by Whole Time Director Ajay Kumar Arora.
This is a routine pre-results intimation. Shareholders should watch for the Q2 FY26 earnings announcement on November 13, 2025, which could influence the stock price. Insider trading restrictions remain in place until after the results are published.